海外の治験の状況「1」での検索結果
8300件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- Phase II clinical study for Camrelizumab combined with Albumin Paclitaxe and Carboplatin in the first-line treatment of advanced non-small cell lung cancer
- advanced non-small cell lung cancer
- China
- 2019-09-29
Recruiting
- Tivozanib - Real World Experience on Tolerability, Patient Reported Outcomes and QoL in 1st line aRCC
- ;C64 - Malignant neoplasm of kidney, except renal pelvis
- Germany
- 2019-09-09
Recruiting
- Real world evidence of PD-L1, TMB prevalence and efficacy of 1st line chemotherapy in these high or low population for stage IV urothelial cancer
- Stage IV urothelial cancer
- Japan
- 2019-09-01
Recruiting
- A real-world study for the efficacy and influencing factors of pemetrexed combined with EGFR-TKIs in the first-line treatment of advanced NSCLC patients
- Lung adenocarcinoma
- China
- 2019-10-09
Recruiting
- A study for efficacy and safety of Camrelizumab combined with Famitinib Malate Capsules in the second-line treatment of advanced non-small cell lung cancer
- Advanced non-small cell lung cancer
- China
- 2019-10-16
Recruiting
- Effect of ultrasound-guided second half line nerve block on pain after open radical hysterectomy
- cervical cancer
- 2019-10-21
Recruiting
- A study on the characteristics of Korean type 2 diabetes mellitus patients suitable for the treatment of GLP-1 agonist
- ;Endocrine, nutritional and metabolic disease
- Korea, Republic of
- 2019-10-24
Recruiting
- A Study to Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian Federation
- HIV-1 Infection
- Russian Federation
- 2019-10-22
Recruiting
- Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment
- Irritable bowel syndrome Digestive System Irritable bowel syndrome
- United Kingdom
- 2019-06-07
Recruiting
- A Phase II Study of Sintilimab Combined With Docetaxel as Second-line Therapy in NSCLC Patients
- Non-small cell lung cancer
- China
- 2019-11-22
Recruiting
- Camrelizumab, Apatinib and Nab-paclitaxel as Second-line Treatment in Advanced Gastric Cancer
- Advanced Gastric Cancer
- China
- 2019-11-27
Recruiting
- A phase II study of 2nd-line FOLFIRI+aflibercept in patients with colorectal cancer resistant to anti-EGFR chemotherapy (HGCSG1801)
- colorectal cancer colorectal cancer;D015179
- none
- 2019-11-19
Recruiting
- GC 2nd Line Durvalumab(MEDI4736)/Tremelimumab Plus Paclitaxel Study
- Metastatic Gastric Cancer
- Korea, Republic of
- 2018-11-21
Recruiting
- First-line Chemotherapy for Recurrent Cervical Cancer
- Recurrent Cervical Carcinoma;Persistent Advanced Cervical Carcinoma;Chemotherapy;Vascular Endothelial Growth Factor 2 Inhibitor;Apatinib;Targeted Therapy
- China
- 2019-12-04
Recruiting
- Clinical Study on the First-line Treatment of Advanced Biliary System Tumors With Tripley Monoclonal Antibody Combined With GEMOX Regimen
- Advanced Biliary Tract Tumors
- China
- 2019-12-06
Recruiting
- Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy
- Non-Small-Cell Lung
- Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Jordan, Korea, Republic of, Lebanon, Netherlands, Poland, Russian Federation, Singapore, Spain, Taiwan, United States
- 2018-07-25
Recruiting
- The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
- Immune Thrombocytopenia
- China
- 2019-12-30
Recruiting
- A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer
- Metastatic Colorectal Cancer
- China
- 2020-01-23
Recruiting
- On-line Cognitive Training for Parkinson's Disease
- Parkinson Disease
- Italy
- 2020-01-18
Recruiting
- Feasibility, Acceptability and Costs of a Multiple First-lines Artemisinin-based Combination Therapies
- Malaria
- Burkina Faso
- 2020-01-21